Table 2 Characteristics of participants (%/mean ± SD)
| Â | Patients with T2D | Persons without T2D |
|---|---|---|
n | 28 | 30 |
Age (years) | 63.4 ± 7.8 | 54.4 ± 10.3 |
Men (%) | 68 | 47 |
Diabetes duration (years) | 16 ± 8 | 0 |
Smokers (%) | 21 | 10 |
BMI (kg/m2) | 32.7 ± 4.5 | 26.4 ± 3.6 |
Microalbuminuria (%) | 50 | 0 |
Prevalent CVD (%) | 21 | 0 |
Total cholesterol (mmol/l) | 3.76 ± 0.71 | 5.10 ± 1.06 |
HDL cholesterol (mmol/l) | 1.33 ± 0.39 | 1.55 ± 0.33 |
LDL cholesterol (mmol/l) | 1.76 ± 0.57 | 2.94 ± 0.93 |
Triglycerides (mmol/l) | 1.45 ± 0.55 | 1.33 ± 0.57 |
Treatment with statins (%) | 96 | 10 |
HbA1c (%) | 7.75 ± 1.04 | 5.52 ± 0.22 |
Therapeutic methods for T2D: Diet only/OAD/insulin/OAD+insulin (%) | 11/14/50/25 | Â |
Systolic blood pressure (mmHg) | 132 ± 19 | 126 ± 13 |
Diastolic blood pressure (mmHg) | 77 ± 9 | 77 ± 8 |
Antihypertensive treatment (%) | 96 | 7 |
Therapeutic method for hypertension: ACEi/ARB/β-blockers/diuretics/CCB (%) | 39/54/11/68/32 | 0/3/0/3/0 |
Mean carotid IMT (mm) | 0.800 ± 0.131 | 0.679 ± 0.105 |